These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16945530)

  • 1. Syntheses and studies of quinolone-cephalosporins as potential anti-tuberculosis agents.
    Zhao G; Miller MJ; Franzblau S; Wan B; Möllmann U
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5534-7. PubMed ID: 16945530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antituberculosis agents. VII. Synthesis and in vitro evaluation of antimycobacterial activity and cytotoxicity of some N-piperazinyl quinolone derivatives.
    Foroumadi A; Soltani F; Asadipour A
    Boll Chim Farm; 2003 Apr; 142(3):130-4. PubMed ID: 12806833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antituberculosis agents IV: in vitro antimycobacterial activity and cytotoxicity of N-piperazinyl quinolone derivatives containing 2-thienyl and 2-furyl moiety.
    Foroumadi A; Soltani F; Mirzaei M
    Pharmazie; 2003 May; 58(5):347-8. PubMed ID: 12779054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro activities of the new quinolone nemonoxacin (TG-873870), gemifloxacin and other quinolones against clinical isolates of Mycobacterium tuberculosis.
    Tan CK; Lai CC; Liao CH; Chou CH; Hsu HL; Huang YT; Hsueh PR
    J Antimicrob Chemother; 2009 Aug; 64(2):428-9. PubMed ID: 19454523
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro activities of the newly synthesised ER-2 against clinical isolates of Mycobacterium tuberculosis susceptible or resistant to antituberculosis drugs.
    Rao SS; Raghunathan R; Ekambaram R; Raghunathan M
    Int J Antimicrob Agents; 2009 Nov; 34(5):451-3. PubMed ID: 19625168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-action cephalosporins: cephalosporin 3'-quaternary ammonium quinolones.
    Albrecht HA; Beskid G; Christenson JG; Durkin JW; Fallat V; Georgopapadakou NH; Keith DD; Konzelmann FM; Lipschitz ER; McGarry DH
    J Med Chem; 1991 Feb; 34(2):669-75. PubMed ID: 1847430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety.
    Emami S; Foroumadi A; Faramarzi MA; Samadi N
    Arch Pharm (Weinheim); 2008 Jan; 341(1):42-8. PubMed ID: 18072241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tubercular agents. Part IV: Synthesis and antimycobacterial evaluation of nitroheterocyclic-based 1,2,4-benzothiadiazines.
    Kamal A; Ahmed SK; Reddy KS; Khan MN; Shetty RV; Siddhardha B; Murthy US; Khan IA; Kumar M; Sharma S; Ram AB
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5419-22. PubMed ID: 17692520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, syntheses, and anti-tuberculosis activities of conjugates of piperazino-1,3-benzothiazin-4-ones (pBTZs) with 2,7-dimethylimidazo [1,2-a]pyridine-3-carboxylic acids and 7-phenylacetyl cephalosporins.
    Majewski MW; Tiwari R; Miller PA; Cho S; Franzblau SG; Miller MJ
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2068-71. PubMed ID: 26951749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimycobacterial activity of econazole against multidrug-resistant strains of Mycobacterium tuberculosis.
    Ahmad Z; Sharma S; Khuller GK; Singh P; Faujdar J; Katoch VM
    Int J Antimicrob Agents; 2006 Dec; 28(6):543-4. PubMed ID: 17101262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel inhibitor of indole-3-glycerol phosphate synthase with activity against multidrug-resistant Mycobacterium tuberculosis.
    Shen H; Wang F; Zhang Y; Huang Q; Xu S; Hu H; Yue J; Wang H
    FEBS J; 2009 Jan; 276(1):144-54. PubMed ID: 19032598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cephalosporin 3'-quinolone esters with a dual mode of action.
    Albrecht HA; Beskid G; Chan KK; Christenson JG; Cleeland R; Deitcher KH; Georgopapadakou NH; Keith DD; Pruess DL; Sepinwall J
    J Med Chem; 1990 Jan; 33(1):77-86. PubMed ID: 2153215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of indolizine derivatives with selective antibacterial activity against Mycobacterium tuberculosis.
    Gundersen LL; Charnock C; Negussie AH; Rise F; Teklu S
    Eur J Pharm Sci; 2007 Jan; 30(1):26-35. PubMed ID: 17079120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antimycobacterial evaluation of certain fluoroquinolone derivatives.
    Zhao YL; Chen YL; Sheu JY; Chen IL; Wang TC; Tzeng CC
    Bioorg Med Chem; 2005 Jun; 13(12):3921-6. PubMed ID: 15911308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-Mycobacterium tuberculosis agents.
    Shiradkar MR; Murahari KK; Gangadasu HR; Suresh T; Kalyan CA; Panchal D; Kaur R; Burange P; Ghogare J; Mokale V; Raut M
    Bioorg Med Chem; 2007 Jun; 15(12):3997-4008. PubMed ID: 17442576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis and antibacterial activity of 7-(3-amino-4-alkoxyimino-1 -piperidyl) -quinolones].
    Wang XY; Guo Q; Wang YC; Liu BQ; Liu ML; Sun LY; Guo HY
    Yao Xue Xue Bao; 2008 Aug; 43(8):819-27. PubMed ID: 18956774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
    Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
    Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
    Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship of truncated analogs of caprazamycins as potential anti-tuberculosis agents.
    Hirano S; Ichikawa S; Matsuda A
    Bioorg Med Chem; 2008 May; 16(9):5123-33. PubMed ID: 18375127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.